Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized study conducted in patients undergoing coronary
revascularization procedures (PCI) through angioplasty. All patients who meet the eligibility
criteria will be randomized to receive, before the procedure, an oral aspirin reload (325 mg)
and to be re-evaluated at 60 minutes, 120 minutes, 6 hours, 48 hours, 5 and 30 day, 3 and 6
months.